179 related articles for article (PubMed ID: 27926627)
21. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
Ishibashi H; Kobayashi M; Takasaki C; Okubo K
Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F
Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
[TBL] [Abstract][Full Text] [Related]
23. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma.
Yajnik S; Rosenzweig KE; Mychalczak B; Krug L; Flores R; Hong L; Rusch VW
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1319-26. PubMed ID: 12873676
[TBL] [Abstract][Full Text] [Related]
24. Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
Soldera SV; Kavanagh J; Pintilie M; Leighl NB; de Perrot M; Cho J; Hope A; Feld R; Bradbury PA
Oncologist; 2019 Jul; 24(7):e510-e517. PubMed ID: 30478189
[TBL] [Abstract][Full Text] [Related]
25. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
[TBL] [Abstract][Full Text] [Related]
26. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
[TBL] [Abstract][Full Text] [Related]
27. Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.
Riesterer O; Ciernik IF; Stahel RA; Xyrafas A; Aebersold DM; Plasswilm L; Mahmut Ozsahin E; Zwahlen DR; Nackaerts K; Zimmermann F; Sabrina Stark L; Weder W; Krayenbuehl J;
Radiother Oncol; 2019 Sep; 138():121-125. PubMed ID: 31252293
[TBL] [Abstract][Full Text] [Related]
28. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
[TBL] [Abstract][Full Text] [Related]
29. Malignant pleural mesothelioma: surgical management in 285 patients.
Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
[TBL] [Abstract][Full Text] [Related]
30. Fifteen years in the evaluation of extrapleural pneumonectomy: Lessons to be learned.
Treasure T; Macbeth F
J Thorac Cardiovasc Surg; 2015 May; 149(5):1382-3. PubMed ID: 25466860
[No Abstract] [Full Text] [Related]
31. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
[TBL] [Abstract][Full Text] [Related]
32. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
[TBL] [Abstract][Full Text] [Related]
33. Local and systemic therapies for malignant pleural mesothelioma.
Gomez D; Tsao AS
Curr Treat Options Oncol; 2014 Dec; 15(4):683-99. PubMed ID: 25266654
[TBL] [Abstract][Full Text] [Related]
34. The recurrence of malignant pleural mesothelioma 14 years after extrapleural pneumonectomy: possible histological transformation.
Kinoshita T; Ishii G; Matsumura Y; Shiozawa T; Aokage K; Hishida T; Yoshida J; Nagai K
Pathol Int; 2012 Nov; 62(11):754-7. PubMed ID: 23121607
[TBL] [Abstract][Full Text] [Related]
35. [Experience in treating patients with malignant pleural mesothelioma].
Uramoto H; Shimokawa H; Baba T; Shigematsu Y; Nagata Y; Ono K; Takenoyama M; Hanagiri T
J UOEH; 2010 Sep; 32(3):257-64. PubMed ID: 20857819
[TBL] [Abstract][Full Text] [Related]
36. [Recent progress in treatment of malignant pleural mesothelioma].
Mahé MA; Cellerin L; Michaud JL; Sagan C; Supiot S; Le Péchoux C
Cancer Radiother; 2005 Nov; 9(6-7):362-5. PubMed ID: 16219479
[TBL] [Abstract][Full Text] [Related]
37. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
[TBL] [Abstract][Full Text] [Related]
38. [Extended extrapleural pneumonectomy by median approach for advanced malignant mesothelioma with right supraclavicular lymph node metastasis--a case report].
Murata S; Kohiyama R; Tanaka M; Miyamoto H; Hata E
Nihon Kyobu Geka Gakkai Zasshi; 1994 Mar; 42(3):404-8. PubMed ID: 8176300
[TBL] [Abstract][Full Text] [Related]
39. Trimodality treatment of malignant pleural mesothelioma.
Batirel HF; Metintas M; Caglar HB; Yildizeli B; Lacin T; Bostanci K; Akgul AG; Evman S; Yuksel M
J Thorac Oncol; 2008 May; 3(5):499-504. PubMed ID: 18449002
[TBL] [Abstract][Full Text] [Related]
40. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma. A treatment option in selected cases?
Takahashi K; Yoshida J; Nishimura M; Nagai K
Jpn J Thorac Cardiovasc Surg; 2001 Feb; 49(2):89-93. PubMed ID: 11257775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
